| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |